Wall Street Veteran Pinpoints No. 1 Biotech Stock
A game-changing medical device is about to make some well-positioned investors very happy.
The company behind this device has more than 100 patents, saw its earnings surge 768% year over year last quarter, has a track record of growth and just signed two major deals…
One with Teva Pharmaceutical, the world’s largest generic drugmaker, with a $12.5 billion market cap.
The other with Pfizer, the world’s largest pharmaceutical corporation with a $228.5 billion market cap.
This New Jersey-based company is perfectly primed for a takeover – very soon.
That’s why Wall Street veteran Jeff Yastine is certain that there is a very unique opportunity for savvy investors.
And at less than $5 per share, the rewards for those who get in NOW could be tremendous.
Yastine just created a special presentation detailing what he believes is the No. 1 biotech stock to invest in today.